ウイルス感染/ワクチン接種を利用して,高親和性T細胞群を腫瘍に集中させる
Alexa Veliz Rios1, Muriel Metko1, Jason Tonne1
1Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA.
まとめ
癌の免疫療法は,既存の抗ウイルスT細胞の反応をリダイレクトすることによって強化できます. この研究は,T細胞を腫瘍にフォーカスさせ,腫瘍を治すために,腫瘍ウイルスまたはCAR-T細胞でSARS-CoV-2抗原を使用することを実証しています.
科学分野:
- 免疫学
- 腫瘍学
- ウイルス学
背景:
- 免疫耐性は,自己腫瘍関連抗原 (TAA) に対するT細胞応答を制限し,がん免疫治療を阻害する.
- ウイルスの感染は 高い親和性を持つT細胞を活性化させ この限界を克服する 戦略を提示します
研究 の 目的:
- SARS-CoV-2抗原に対する既存の抗ウイルスT細胞メモリの使用を調査し,抗腫瘍免疫を強化する.
- 腫瘍を標的とするウイルス抗原の腫瘍解毒ウイルス (OV) とキメリック抗原受容体 (CAR) -T細胞配送を調査する.
主な方法:
- SARS-CoV-2抗原 (メムまたはスパイクタンパク質) を使用した異質なプライムおよびOV/ブースト戦略.
- SARS-CoV-2の抗原発現ベクトルを供給するキメリック抗原受容体 (CAR) -T細胞療法.
- Sタンパク質ワクチンのS特異的なCAR- T細胞のインビボ増強.
主要な成果:
- CD8+T細胞依存性腫瘍の治癒は,T細胞フォーカスのSARS-CoV-2抗原を用いて達成され,TAAに対してエピトープが広がった証拠が示されました.
- CAR-T細胞は,免疫前のマウスでも,SARS-CoV-2抗原ベクトルを腫瘍に成功的に送達した.
- CAR- T細胞のインビオ増強は抗腫瘍活性と持続性を高めました.
結論:
- OVまたはCAR-T細胞によるウイルスの抗原の伝達による既存の抗ウイルスT細胞応答を活用することは,がん免疫療法のための高親和性T細胞を生成する有効な戦略です.
- このアプローチは,高アフィニティの抗腫瘍T細胞が容易に入手できない場合に,治療の代替手段を提供します.
関連する概念動画
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
Cancer Vaccines
509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509
Cytotoxic T Cells-mediated Immune Response
1.9K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.9K
Immune Response Against Viral Pathogens
917
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
917
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K


